Erasmus School of Health Policy & Management
External PhD candidate | Health Technology Assessment (HTA)
- heine@eshpm.eur.nl
More information
Work
- Nicole Huang, Laura A Hatfield, Saeed Al-Azazi, Pieter Bakx, Amitava Banerjee, Nitzan Burrack, Yu Chin Chen, Christina Fu, Carlos Godoy Junior, Renaud Heine, Dennis T. Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Bheeshma Ravi, Therese A Stukel, Carin de Groot, Peter Cram & Bruce E. Landon (2024) - Comparison of Management and Outcomes of Hip Fractures Among Low- and High-Income Patients in Six High-Income Countries - Journal of General Internal Medicine - doi: 10.1007/s11606-024-09274-9
- Renaud Heine (2024) - Navigating reimbursement decision making of innovatives medicnes: Investigating the balance between patient access, pricing, risk mitigation and a sustainable healthcare system.
- Renaud J.S.D. Heine, Ron H.J. Mathijssen, Floor A.J. Verbeek, Chantal Van Gils & Carin A. Uyl-de Groot (2024) - Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands - Value in Health, 27 (10), 1367-1372 - doi: 10.1016/j.jval.2024.06.003 - [link]
- Hannah Lu, Laura A Hatfield, Saeed Al-Azazi, Pieter Bakx, Amitava Banerjee, Nitzan Burrack, Yu-Chin Chen, Christina Fu, Michal Gordon, Renaud Heine, Nicole Huang, Dennis T Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin A Uyl-de Groot, Gabe Weinreb, Bruce E Landon & Peter Cram (2024) - Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative - Circulation. Cardiovascular quality and outcomes, 17 (3), E010144 - doi: 10.1161/CIRCOUTCOMES.123.010144 - [link]
- R. J.S.D. Heine, F. W. Thielen, R. H.J. Mathijssen, R. W.F. van Leeuwen, M. G. Franken & C. A. Uyl-de Groot (2024) - Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab - PLoS ONE, 19 (2 February) - doi: 10.1371/journal.pone.0293264 - [link]
- Nitzan Burrack, Laura A. Hatfield, Pieter Bakx, Amitava Banerjee, Yu Chin Chen, Christina Fu, Carlos Godoy Junior, Michal Gordon, Renaud Heine, Nicole Huang, Dennis T. Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin de Groot, Bheeshma Ravi, Saeed Al-Azazi, Gabe Weinreb, Peter Cram & Bruce E. Landon (2023) - Variation in care for patients presenting with hip fracture in six high-income countries: A cross-sectional cohort study - Journal of the American Geriatrics Society, 71 (12), 3780-3791 - doi: 10.1111/jgs.18530 - [link]
- Bruce E. Landon, Laura A. Hatfield, Pieter Bakx, Amitava Banerjee, Yu Chin Chen, Christina Fu, Michal Gordon, Renaud Heine, Nicole Huang, Dennis T. Ko, Lisa M. Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A. Stukel, Carin Uyl-De Groot, Lin Yan, Gabe Weinreb & Peter Cram (2023) - Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries - JAMA, 329 (13), 1088-1097 - doi: 10.1001/jama.2023.1699 - [link]
- Frederick W. Thielen, Renaud J.S.D. Heine, Sibren van den Berg, Renske M.T.ten Ham & Carin A.Uyl de Groot (2022) - Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma - Cytotherapy, 24 (12), 1245-1258 - doi: 10.1016/j.jcyt.2022.09.002 - [link]
- Frederick W. Thielen, Renaud J.S.D. Heine, Sibren Van Den Berg, Renske M.T. Ten Ham & Carin A. Uyl-De Groot (2022) - Kostprijs-plusmodel geeft inzicht in reële prijzen gentherapieën - Pharmaceutisch Weekblad, 157 (47), 18-20 - [link]
- Stefan Rabbe, Meilin Möllenkamp, Benedetta Pongiglione, Hedwig Blommestein, Pim Wetzelaer, Renaud Heine & Jonas Schreyögg (2022) - Variation in the utilization of medical devices across Germany, Italy, and the Netherlands: A multilevel approach - Health Economics (United Kingdom), 31 (S1), 135-156 - doi: 10.1002/hec.4492 - [link]
Module Knowledge
- Level
- bachelor 1
- Year Level
- bachelor 1
Master Thesis HE
- Year Level
- master, master
Master Thesis HEPL
- Level
- master
- Year Level
- master
Pharmaceutical Pricing and Market Acces
- Year Level
- master, master, master, master
Health Technology Assessment
- Year Level
- master, master, master
